Form 4 for PRCT PROCEPT BioRobotics Corp
Accepted 2022-06-22 00:00:00 ET · period of report 2022-06-21 · accession 0001628280-22-017818 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-06-22 | 2022-06-21 | PRCT | Krummel Thomas M | Dir | S - Sale+OE | $35.99 | -20.0K | 92.4K | -18% | -$719.7K |
| DM | 2022-06-22 | 2022-06-21+ | PRCT | Krummel Thomas M | Dir | M - OptEx | $2.84 | +20.0K | 93.4K | +27% | +$56.9K |
| DM | 2022-06-22 | 2022-06-21+ | PRCT | Krummel Thomas M | Dir | M - OptEx | $0.00 | -20.0K | 19.5K | -51% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-21 | S | D | 6,834 | $36.14 | 85,609 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $38.15. |
| 2 | Common | Common Stock | 2022-06-21 | M | A | 6,834 | $4.51 | 100,231 | D | — | — | |
| 3 | Common | Common Stock | 2022-06-22 | M | A | 2,689 | $4.51 | 102,920 | D | — | — | |
| 4 | Common | Common Stock | 2022-06-21 | S | D | 2,689 | $35.00 | 82,920 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.01. |
| 5 | Common | Common Stock | 2022-06-21 | M | A | 10,477 | $1.33 | 93,397 | D | — | — | |
| 6 | Common | Common Stock | 2022-06-21 | S | D | 10,477 | $36.14 | 92,443 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $38.15. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (4) to this Form 4. |
| 7 | Derivative | Stock Option (Right to Buy) | 2022-06-21 | M | D | 10,477 | $0.00 | 0 | D | $1.33 · — to 2025-09-18 | 10,477 Common Stock | (F5) The option is fully vested and exercisable. |
| 8 | Derivative | Stock Option (Right to Buy) | 2022-06-22 | M | D | 2,689 | $0.00 | 16,792 | D | $4.51 · — to 2028-04-26 | 2,689 Common Stock | (F5) The option is fully vested and exercisable. |
| 9 | Derivative | Stock Option (Right to Buy) | 2022-06-21 | M | D | 6,834 | $0.00 | 19,481 | D | $4.51 · — to 2028-04-26 | 6,834 Common Stock | (F5) The option is fully vested and exercisable. |